Development of at-home sample collection logistics for large-scale seroprevalence studies.
other
Where this comes from
- Record sourced from PubMed, PMID 34735477.
- Also identified by DOI 10.1371/journal.pone.0258516 and PMC identifier 8568136.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Serological studies rely on the recruitment of representative cohorts; however, such efforts are specially complicated by the conditions surrounding the COVID19 pandemic. We aimed to design and implement a fully remote methodology for conducting safe serological surveys that also allow for the engagement of representative study populations. This design was well-received and effective. 2,066 participants ≥18 years old were enrolled, reflecting the ethnic and racial composition of Massachusetts. >70% of them reported being satisfied/extremely satisfied with the online enrollment and at-home self-collection of blood samples. While 18.6% reported some discomfort experienced with the collection process, 72.2% stated that they would be willing to test weekly if enrolled in a long-term study. High engagement and positive feedback from participants, as well as the quality of self-collected specimens, point to the usefulness of this fully remote, self-collection-based study design for future safer and efficient population-level serological surveys.
Medical subject headings
- COVID-19
- SARS-CoV-2
- Seroepidemiologic Studies
- Specimen Handling